Inventor · disambiguated record
Partha S. Chowdhury
Also filed as: CHOWDHURY PARTHA · CHOWDHURY PARTHA S · CHOWDHURY PARTHA SARATHI
29 granted patents·19 pending applications·422 citations·filing 1998–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0197US7081518B1Anti-mesothelin antibodies having high binding affinityUS HEALTH·Filed 2000·Granted Jul 25, 2006·109 cites·17 claims
- 0295US9527927B2Modified polypeptides for bispecific antibody scaffoldsMEDIMMUNE LLC·Filed 2012·Granted Dec 27, 2016·41 cites·11 claims
- 0392US7709252B2Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their useUS HEALTH·Filed 2008·Granted May 4, 2010·13 cites·16 claims
- 0492US7368110B2Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their useUS HEALTH·Filed 2004·Granted May 6, 2008·38 cites·11 claims
- 0591US10730934B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2018·Granted Aug 4, 2020·6 cites·21 claims
- 0690US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0790US9879070B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2013·Granted Jan 30, 2018·17 cites·6 claims
- 0889US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0989US7550569B2Antibodies that specifically bind to GMADHUMAN GENOME SCIENCE INC·Filed 2004·Granted Jun 23, 2009·22 cites·2 claims
- 1089US6809184B1Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their useUS HEALTH·Filed 1998·Granted Oct 26, 2004·69 cites·52 claims
- 1188US11608375B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Mar 21, 2023·2 cites·16 claims
- 1288US10829554B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Nov 10, 2020·5 cites·20 claims
- 1388US8137670B2Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cellsWU HERREN·Filed 2006·Granted Mar 20, 2012·10 cites·20 claims
- 1487US9527905B2Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of useSELLMAN BRET·Filed 2012·Granted Dec 27, 2016·23 cites·9 claims
- 1587US9220775B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Dec 29, 2015·15 cites·39 claims
- 1687US7129332B2Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereofUS HEALTH·Filed 2001·Granted Oct 31, 2006·29 cites·30 claims
- 1784US11447543B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2020·Granted Sep 20, 2022·1 cites·12 claims
- 1881US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 1979US10040857B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 7, 2018·3 cites·56 claims
- 2077US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 2175US8404236B2Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cellsWU HERREN·Filed 2012·Granted Mar 26, 2013·2 cites·17 claims
- 2275US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2373US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 2472US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 2570US10775388B2Methods of using antibodies to determine periostin levels in a sampleMEDIMMUNE LLC·Filed 2015·Granted Sep 15, 2020·1 cites·23 claims
- 2667US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 2767US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 2865US11091554B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Aug 17, 2021·0 cites·20 claims
- 2963US2024150437A1Immune repertoire miningMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 3061US2025368756A1Enhanced protein compositionsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 3160US2010292441A1Antibodies that specifically bind to GMADTEVA BIOPHARMACEUTICALS USA IN·Filed 2009·Application pending·0 cites
- 3257US2025320304A1Compositions comprising enhanced multispecific binding agents for an immune responseJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3355US9862762B2Monoclonal antibodies which bind human periostinMEDIMMUNE LLC·Filed 2015·Granted Jan 9, 2018·0 cites·18 claims
- 3455US2018179272A1Novel assay to detect human periostinMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 3553US2023279092A1Immunocytokines for treatment of autoimmune and inflammatory conditionsVIELA BIO INC·Filed 2021·Application pending·0 cites
- 3652US11305012B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Apr 19, 2022·0 cites·14 claims
- 3751US2017073397A1MrkA Polypeptides, Antibodies, and Uses ThereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 3850US2019352425A1Assay to detect human dpp-4MEDIMMUNE LLC·Filed 2019·Application pending·0 cites
- 3950US2010166746A1High potency recombinant antibodies, methods for producing them and use in cancer therapyMEDLMMUNE WAY·Filed 2007·Application pending·0 cites
- 4049US2024166731A1Humanized antibodies against paired helical filament tau and uses thereofJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 4148US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 4247US2019062411A1Mrka polypeptides, antibodies, and uses thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 4346US10351630B2Assay to detect human DPP-4MEDIMMUNE LLC·Filed 2016·Granted Jul 16, 2019·0 cites·15 claims
- 4445US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 4545US2019367585A1Immune repertoire miningMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 4643US2015110802A1Antibody production methodsMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 4739US2019367605A1Binding Molecules Specific For ASCT2 And Uses ThereofMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 4836US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Partha S. Chowdhury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →